INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 141 filers reported holding INTERSECT ENT INC in Q3 2017. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $5,727,000 | -4.7% | 274,271 | +4.5% | 0.04% | -17.0% |
Q4 2020 | $6,008,000 | +35.9% | 262,369 | -3.2% | 0.05% | +15.2% |
Q3 2020 | $4,420,000 | +15.4% | 271,007 | -4.2% | 0.05% | +12.2% |
Q2 2020 | $3,829,000 | +70.0% | 282,790 | +48.8% | 0.04% | +41.4% |
Q1 2020 | $2,252,000 | +562.4% | 190,032 | +1290.1% | 0.03% | +866.7% |
Q4 2019 | $340,000 | +33.9% | 13,670 | -8.4% | 0.00% | 0.0% |
Q3 2019 | $254,000 | -87.2% | 14,930 | -78.3% | 0.00% | -89.3% |
Q3 2018 | $1,978,000 | +3.2% | 68,797 | +34.5% | 0.03% | -6.7% |
Q2 2018 | $1,916,000 | +6.3% | 51,151 | +11.6% | 0.03% | 0.0% |
Q1 2018 | $1,802,000 | -46.4% | 45,851 | -55.8% | 0.03% | -49.2% |
Q4 2017 | $3,361,000 | +137.4% | 103,722 | +128.2% | 0.06% | +110.7% |
Q3 2017 | $1,416,000 | +38.7% | 45,462 | +24.5% | 0.03% | +27.3% |
Q2 2017 | $1,021,000 | -11.1% | 36,512 | -45.5% | 0.02% | -4.3% |
Q1 2017 | $1,148,000 | -20.9% | 66,936 | -44.2% | 0.02% | -17.9% |
Q4 2016 | $1,452,000 | – | 120,029 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |